Zhifei Biotech (300122.SZ) issued an announcement. On November 23, 2023, the company and Chongqing Chenan Biotech...
According to the Zhitong Finance App, Zhifei Biotech (300122.SZ) issued an announcement. On November 23, 2023, the company, Chongqing Chenan Biopharmaceutical Co., Ltd. (“Chenan Biotech”), Chongqing Zhirui Investment Co., Ltd. (“Zhirui Investment”), and Zhang Gaoxia reached a preliminary agreement on Zhifei Biotech's plan to acquire Zhirui Investment in cash and Zhang Gaoxia's 100% shares in Chenan Biotech and signed an “Intentional Share Acquisition Agreement”.
The company said that in order to deepen the company's self-developed technology and product layout in biopharmaceuticals and achieve the development goal of building a “world-class national biopharmaceutical enterprise”, the company plans to inject Chen'an Biotech into the company through this transaction. The company's business map will extend to metabolic diseases such as diabetes and obesity. At the same time, the company will also enter the field of therapeutic biopharmaceuticals.